Publications:

Early onset HER2-positive breast cancer is associated with germline TP53 mutations.

Cancer

Melhem-Bertrandt, Amal A; Bojadzieva, Jasmina J; Ready, Kaylene J KJ; Obeid, Elias E; Liu, Diane D DD; Gutierrez-Barrera, Angelica M AM; Litton, Jennifer K JK; Olopade, Olufunmilayo I OI; Hortobagyi, Gabriel N GN; Strong, Louise C LC; Arun, Banu K BK

Publication Date: 2012-02-15

Variant appearance in text: HER2: 847C>T

PubMed Link: 21761402

Variant Present in the following documents:

• Main text

View BVdb publication page